LPTX - Wall Street Estimates - Leap Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 0.4668

0.755 %

$ 17.9 M

Market Cap

-0.28

P/E

Price Target Average

1078.23%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

27.05%

Net Income Estimate

26.44%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Leap Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for LPTX of $5.5 , with forecasts ranging from a low of $5.5 to a high of $5.5 .

LPTX Lowest Price Target Wall Street Target

5.5 USD 1078.23%

LPTX Average Price Target Wall Street Target

5.5 USD 1078.23%

LPTX Highest Price Target Wall Street Target

5.5 USD 1078.23%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free